Vaxcyte Inc. Common Stock vs Park Hotels & Resorts Inc. Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Park Hotels & Resorts Inc. Common Stock trades at $15.12 (market cap $3.14B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 3.3× Park Hotels & Resorts Inc. Common Stock's market cap, and Park Hotels & Resorts Inc. Common Stock pays a 6.41% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Park Hotels & Resorts Inc. Common Stock for 0 Days on average.
| PCVX | PK | |
|---|---|---|
Market Cap | $10.51B | $3.14B |
Volume | 2,644,694 | 3,553,985 |
Sector | Health | Real Estate |
52-Week High | $73.82 | $16.17 |
52-Week Low | $40.32 | $9.84 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $6.98B |
Dividend Yield | — | 6.41% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →Park Hotels & Resorts Inc. is a US lodging REIT, spun off from Hilton Worldwide in 2017, that owns a portfolio of premium-branded hotels and resorts in major urban, resort, and convention markets.
Read more on PK →